Donate to the Associates Board
THE ASSOCIATES BOARD OF THE UCCRF is comprised primarily of young philanthropists committed to the fight against cancer. Although it is the UCCRF’s newest Board, the Associates Board has already made significant contributions to advance cancer research and has helped the University of Chicago maintain its reputation as a pioneer in the study and treatment of malignant mesothelioma and the development of immunotherapies. This approach to treatment encourages our own immune systems to attack cancer and enhances its effectiveness. Since its inception, the Associates Board has provided more than $400,000 in funding to underwrite mesothelioma and immunology research.